Global Oncology Based Preclinical CRO Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 275
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Oncology Based Preclinical CRO Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Oncology Based Preclinical CRO Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Oncology Based Preclinical CRO Market: Top Key Players
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Oncology Based Preclinical CRO Breakdown Data by Type
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Breakdown Data by Application
In Vitro
In Vivo
Global Oncology Based Preclinical CRO Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Oncology Based Preclinical CRO Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Oncology Based Preclinical CRO Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Oncology Based Preclinical CRO Market: Top Key Players
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Oncology Based Preclinical CRO Breakdown Data by Type
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Breakdown Data by Application
In Vitro
In Vivo
Global Oncology Based Preclinical CRO Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Oncology Based Preclinical CRO Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Based Preclinical CRO Revenue
1.4 Market Analysis by Type
1.4.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Blood Cancer
1.4.3 Solid Tumors
1.4.4 Others
1.5 Market by Application
1.5.1 Global Oncology Based Preclinical CRO Market Share by Application: 2022 VS 2030
1.5.2 In Vitro
1.5.3 In Vivo
1.6 Coronavirus Disease 2019 (Covid-19): Oncology Based Preclinical CRO Industry Impact
1.6.1 How the Covid-19 is Affecting the Oncology Based Preclinical CRO Industry
1.6.1.1 Oncology Based Preclinical CRO Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oncology Based Preclinical CRO Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oncology Based Preclinical CRO Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Oncology Based Preclinical CRO Market Perspective (2016-2030)
2.2 Oncology Based Preclinical CRO Growth Trends by Regions
2.2.1 Oncology Based Preclinical CRO Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Oncology Based Preclinical CRO Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oncology Based Preclinical CRO Market Growth Strategy
2.3.6 Primary Interviews with Key Oncology Based Preclinical CRO Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Market Size
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2016-2021)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2016-2021)
3.1.3 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.2.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2021
3.3 Oncology Based Preclinical CRO Key Players Head office and Area Served
3.4 Key Players Oncology Based Preclinical CRO Product Solution and Service
3.5 Date of Enter into Oncology Based Preclinical CRO Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2016-2021)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2022-2030)
5 Oncology Based Preclinical CRO Breakdown Data by Application (2016-2030)
5.1 Global Oncology Based Preclinical CRO Market Size by Application (2016-2021)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2016-2021)
6.2 Oncology Based Preclinical CRO Key Players in North America (2016-2021)
6.3 North America Oncology Based Preclinical CRO Market Size by Type (2016-2021)
6.4 North America Oncology Based Preclinical CRO Market Size by Application (2016-2021)
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2016-2021)
7.2 Oncology Based Preclinical CRO Key Players in Europe (2016-2021)
7.3 Europe Oncology Based Preclinical CRO Market Size by Type (2016-2021)
7.4 Europe Oncology Based Preclinical CRO Market Size by Application (2016-2021)
8 China
8.1 China Oncology Based Preclinical CRO Market Size (2016-2021)
8.2 Oncology Based Preclinical CRO Key Players in China (2016-2021)
8.3 China Oncology Based Preclinical CRO Market Size by Type (2016-2021)
8.4 China Oncology Based Preclinical CRO Market Size by Application (2016-2021)
(2016-2021)
(2016-2021)
9 Key Players Profiles
9.1 Crown Bioscience
9.1.1 Crown Bioscience Company Details
9.1.2 Crown Bioscience Business Overview and Its Total Revenue
9.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
9.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.1.5 Crown Bioscience Recent Development
9.2 Charles River
9.2.1 Charles River Company Details
9.2.2 Charles River Business Overview and Its Total Revenue
9.2.3 Charles River Oncology Based Preclinical CRO Introduction
9.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.2.5 Charles River Recent Development
9.3 ICON
9.3.1 ICON Company Details
9.3.2 ICON Business Overview and Its Total Revenue
9.3.3 ICON Oncology Based Preclinical CRO Introduction
9.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.3.5 ICON Recent Development
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Company Details
9.4.2 Eurofins Scientific Business Overview and Its Total Revenue
9.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
9.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.4.5 Eurofins Scientific Recent Development
9.5 Taconic Biosciences
9.5.1 Taconic Biosciences Company Details
9.5.2 Taconic Biosciences Business Overview and Its Total Revenue
9.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
9.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.5.5 Taconic Biosciences Recent Development
9.6 Covance
9.6.1 Covance Company Details
9.6.2 Covance Business Overview and Its Total Revenue
9.6.3 Covance Oncology Based Preclinical CRO Introduction
9.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.6.5 Covance Recent Development
9.7 EVOTEC
9.7.1 EVOTEC Company Details
9.7.2 EVOTEC Business Overview and Its Total Revenue
9.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
9.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.7.5 EVOTEC Recent Development
9.8 The Jackson Laboratory
9.8.1 The Jackson Laboratory Company Details
9.8.2 The Jackson Laboratory Business Overview and Its Total Revenue
9.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
9.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.8.5 The Jackson Laboratory Recent Development
9.9 MI Bioresearch
9.9.1 MI Bioresearch Company Details
9.9.2 MI Bioresearch Business Overview and Its Total Revenue
9.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
9.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.9.5 MI Bioresearch Recent Development
9.10 Champion Oncology
9.10.1 Champion Oncology Company Details
9.10.2 Champion Oncology Business Overview and Its Total Revenue
9.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
9.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.10.5 Champion Oncology Recent Development
9.11 Wuxi AppTec.
10.11.1 Wuxi AppTec. Company Details
10.11.2 Wuxi AppTec. Business Overview and Its Total Revenue
10.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
10.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.11.5 Wuxi AppTec. Recent Development
9.12 Xentech
10.12.1 Xentech Company Details
10.12.2 Xentech Business Overview and Its Total Revenue
10.12.3 Xentech Oncology Based Preclinical CRO Introduction
10.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.12.5 Xentech Recent Development
9.13 Living Tumor Laboratory
10.13.1 Living Tumor Laboratory Company Details
10.13.2 Living Tumor Laboratory Business Overview and Its Total Revenue
10.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
10.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.13.5 Living Tumor Laboratory Recent Development
10 Analyst's Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Based Preclinical CRO Revenue
1.4 Market Analysis by Type
1.4.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Blood Cancer
1.4.3 Solid Tumors
1.4.4 Others
1.5 Market by Application
1.5.1 Global Oncology Based Preclinical CRO Market Share by Application: 2022 VS 2030
1.5.2 In Vitro
1.5.3 In Vivo
1.6 Coronavirus Disease 2019 (Covid-19): Oncology Based Preclinical CRO Industry Impact
1.6.1 How the Covid-19 is Affecting the Oncology Based Preclinical CRO Industry
1.6.1.1 Oncology Based Preclinical CRO Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oncology Based Preclinical CRO Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oncology Based Preclinical CRO Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Oncology Based Preclinical CRO Market Perspective (2016-2030)
2.2 Oncology Based Preclinical CRO Growth Trends by Regions
2.2.1 Oncology Based Preclinical CRO Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Oncology Based Preclinical CRO Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oncology Based Preclinical CRO Market Growth Strategy
2.3.6 Primary Interviews with Key Oncology Based Preclinical CRO Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Market Size
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2016-2021)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2016-2021)
3.1.3 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.2.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2021
3.3 Oncology Based Preclinical CRO Key Players Head office and Area Served
3.4 Key Players Oncology Based Preclinical CRO Product Solution and Service
3.5 Date of Enter into Oncology Based Preclinical CRO Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2016-2021)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2022-2030)
5 Oncology Based Preclinical CRO Breakdown Data by Application (2016-2030)
5.1 Global Oncology Based Preclinical CRO Market Size by Application (2016-2021)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2016-2021)
6.2 Oncology Based Preclinical CRO Key Players in North America (2016-2021)
6.3 North America Oncology Based Preclinical CRO Market Size by Type (2016-2021)
6.4 North America Oncology Based Preclinical CRO Market Size by Application (2016-2021)
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2016-2021)
7.2 Oncology Based Preclinical CRO Key Players in Europe (2016-2021)
7.3 Europe Oncology Based Preclinical CRO Market Size by Type (2016-2021)
7.4 Europe Oncology Based Preclinical CRO Market Size by Application (2016-2021)
8 China
8.1 China Oncology Based Preclinical CRO Market Size (2016-2021)
8.2 Oncology Based Preclinical CRO Key Players in China (2016-2021)
8.3 China Oncology Based Preclinical CRO Market Size by Type (2016-2021)
8.4 China Oncology Based Preclinical CRO Market Size by Application (2016-2021)
(2016-2021)
(2016-2021)
9 Key Players Profiles
9.1 Crown Bioscience
9.1.1 Crown Bioscience Company Details
9.1.2 Crown Bioscience Business Overview and Its Total Revenue
9.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
9.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.1.5 Crown Bioscience Recent Development
9.2 Charles River
9.2.1 Charles River Company Details
9.2.2 Charles River Business Overview and Its Total Revenue
9.2.3 Charles River Oncology Based Preclinical CRO Introduction
9.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.2.5 Charles River Recent Development
9.3 ICON
9.3.1 ICON Company Details
9.3.2 ICON Business Overview and Its Total Revenue
9.3.3 ICON Oncology Based Preclinical CRO Introduction
9.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.3.5 ICON Recent Development
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Company Details
9.4.2 Eurofins Scientific Business Overview and Its Total Revenue
9.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
9.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.4.5 Eurofins Scientific Recent Development
9.5 Taconic Biosciences
9.5.1 Taconic Biosciences Company Details
9.5.2 Taconic Biosciences Business Overview and Its Total Revenue
9.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
9.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.5.5 Taconic Biosciences Recent Development
9.6 Covance
9.6.1 Covance Company Details
9.6.2 Covance Business Overview and Its Total Revenue
9.6.3 Covance Oncology Based Preclinical CRO Introduction
9.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.6.5 Covance Recent Development
9.7 EVOTEC
9.7.1 EVOTEC Company Details
9.7.2 EVOTEC Business Overview and Its Total Revenue
9.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
9.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.7.5 EVOTEC Recent Development
9.8 The Jackson Laboratory
9.8.1 The Jackson Laboratory Company Details
9.8.2 The Jackson Laboratory Business Overview and Its Total Revenue
9.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
9.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.8.5 The Jackson Laboratory Recent Development
9.9 MI Bioresearch
9.9.1 MI Bioresearch Company Details
9.9.2 MI Bioresearch Business Overview and Its Total Revenue
9.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
9.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.9.5 MI Bioresearch Recent Development
9.10 Champion Oncology
9.10.1 Champion Oncology Company Details
9.10.2 Champion Oncology Business Overview and Its Total Revenue
9.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
9.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2016-2021)
9.10.5 Champion Oncology Recent Development
9.11 Wuxi AppTec.
10.11.1 Wuxi AppTec. Company Details
10.11.2 Wuxi AppTec. Business Overview and Its Total Revenue
10.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
10.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.11.5 Wuxi AppTec. Recent Development
9.12 Xentech
10.12.1 Xentech Company Details
10.12.2 Xentech Business Overview and Its Total Revenue
10.12.3 Xentech Oncology Based Preclinical CRO Introduction
10.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.12.5 Xentech Recent Development
9.13 Living Tumor Laboratory
10.13.1 Living Tumor Laboratory Company Details
10.13.2 Living Tumor Laboratory Business Overview and Its Total Revenue
10.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
10.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2016-2021)
10.13.5 Living Tumor Laboratory Recent Development
10 Analyst's Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI